Lonza Group
SGS SA
WuXiPharmaTech
BSL Bioservice
Merck KGaA
Cytovance Biologics
Toxikon Corporation
Charles River Laboratories International
Sigma-Aldrich Corporation
Avance Biosciences
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL BIOLOGICAL SAFETY TESTING INDUSTRY
2.1 Summary about Biological Safety Testing Industry
2.2 Biological Safety Testing Market Trends
2.2.1 Biological Safety Testing Production & Consumption Trends
2.2.2 Biological Safety Testing Demand Structure Trends
2.3 Biological Safety Testing Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Adventitious Agents Detection Test
4.2.2 Cell Line Authentication and Characterization tests
4.2.3 Bioburden Testing
4.2.4 Endotoxin Tests
4.2.5 Sterility Testing
4.2.6 Residual Host Contaminant Detection Tests
4.2.7 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Blood Products
4.3.2 Stem Cell Products
4.3.3 Cellular and Gene Therapy Products
4.3.4 Tissue Products
4.3.5 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Adventitious Agents Detection Test
5.2.2 Cell Line Authentication and Characterization tests
5.2.3 Bioburden Testing
5.2.4 Endotoxin Tests
5.2.5 Sterility Testing
5.2.6 Residual Host Contaminant Detection Tests
5.2.7 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Blood Products
5.3.2 Stem Cell Products
5.3.3 Cellular and Gene Therapy Products
5.3.4 Tissue Products
5.3.5 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Adventitious Agents Detection Test
6.2.2 Cell Line Authentication and Characterization tests
6.2.3 Bioburden Testing
6.2.4 Endotoxin Tests
6.2.5 Sterility Testing
6.2.6 Residual Host Contaminant Detection Tests
6.2.7 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Blood Products
6.3.2 Stem Cell Products
6.3.3 Cellular and Gene Therapy Products
6.3.4 Tissue Products
6.3.5 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Adventitious Agents Detection Test
7.2.2 Cell Line Authentication and Characterization tests
7.2.3 Bioburden Testing
7.2.4 Endotoxin Tests
7.2.5 Sterility Testing
7.2.6 Residual Host Contaminant Detection Tests
7.2.7 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Blood Products
7.3.2 Stem Cell Products
7.3.3 Cellular and Gene Therapy Products
7.3.4 Tissue Products
7.3.5 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Adventitious Agents Detection Test
8.2.2 Cell Line Authentication and Characterization tests
8.2.3 Bioburden Testing
8.2.4 Endotoxin Tests
8.2.5 Sterility Testing
8.2.6 Residual Host Contaminant Detection Tests
8.2.7 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Blood Products
8.3.2 Stem Cell Products
8.3.3 Cellular and Gene Therapy Products
8.3.4 Tissue Products
8.3.5 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Adventitious Agents Detection Test
9.2.2 Cell Line Authentication and Characterization tests
9.2.3 Bioburden Testing
9.2.4 Endotoxin Tests
9.2.5 Sterility Testing
9.2.6 Residual Host Contaminant Detection Tests
9.2.7 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Blood Products
9.3.2 Stem Cell Products
9.3.3 Cellular and Gene Therapy Products
9.3.4 Tissue Products
9.3.5 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Lonza Group
10.1.2 SGS SA
10.1.3 WuXiPharmaTech
10.1.4 BSL Bioservice
10.1.5 Merck KGaA
10.1.6 Cytovance Biologics
10.1.7 Toxikon Corporation
10.1.8 Charles River Laboratories International
10.1.9 Sigma-Aldrich Corporation
10.1.10 Avance Biosciences
10.2 Biological Safety Testing Sales Date of Major Players (2017-2020e)
10.2.1 Lonza Group
10.2.2 SGS SA
10.2.3 WuXiPharmaTech
10.2.4 BSL Bioservice
10.2.5 Merck KGaA
10.2.6 Cytovance Biologics
10.2.7 Toxikon Corporation
10.2.8 Charles River Laboratories International
10.2.9 Sigma-Aldrich Corporation
10.2.10 Avance Biosciences
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
